The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease

The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease

M. Matsuyama, A. Moriya, K. Shimizu, N. Kokuho, Y. Miura, S. Otsuka, T. Kiwamoto, K. Hayashihara, T. Saito (Nakagun Tokai-mura, Japan)

Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections

Session: Treatment and prevention of lower respiratory tract infections
Session type: Thematic Poster Session
Number: 2439

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Matsuyama, A. Moriya, K. Shimizu, N. Kokuho, Y. Miura, S. Otsuka, T. Kiwamoto, K. Hayashihara, T. Saito (Nakagun Tokai-mura, Japan). The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease. Eur Respir J 2009; 34: Suppl. 53, 2439

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Pulmonary tuberculosis presentation – Late diagnosis, advanced disease Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Outcome of zinc & vit-A supplementation in the treatment multidrug resistance pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009
Assessment of molecular assays for detection of MDR Mycobacterium tuberculosis resistant to second-line injectable drugs Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
Regional reference centre for multi-drug resistant tuberculosis – 11 months of activity Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Unexpectedly high incidence of pneumothorax in patients with pulmonary Mycobacterium avium complex infection Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010
Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009
Helicobacter pylori infection in COPD Source: Annual Congress 2010 - Various aspects of respiratory epidemiology Year: 2010
Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Destroyed lung secondary to tuberculosis – Surgical options Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012
Accompanying therapy of patients with extensive drug-resistant (xdr) lung tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Airway resistances: R_aw, sR_aw, sR_eff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010
Evaluation of pulmonary diffusion: TL_CO or K_CO? Source: Annual Congress 2010 - Advances in lung function I Year: 2010
T spot TB reactivity – ²to treat or not to treat² Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009